Buvalor 5 mcg/h Transdermal Patch belongs to a class of drugs called 'opioid analgesics' primarily used to treat, prevent and treat severe pain. Pain can be temporary (acute) or long-lasting (chronic) in nature. Acute pain is caused by damage to the tissues of the muscle, bone, or other organs for a short time. Chronic pain lasts for a long duration and is caused due to pathologies like nerve damage and osteoarthritis.

Buvalor 5 mcg/h Transdermal Patch contains 'Buprenorphine', an opioid partial agonist-antagonist. It works by blocking a chemical messenger in the brain responsible for causing pain. This provides pain relief by acting on specific receptors in the brain.

Use Buvalor 5 mcg/h Transdermal Patch as advised by your doctor. You may experience certain side effects in some cases, including drowsiness, dry mouth, vomiting, blurred vision, constipation, application site reactions, dizziness or tiredness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Buvalor 5 mcg/h Transdermal Patch should be avoided if you are allergic to it or any of its ingredients or opioids. Do not use Buvalor 5 mcg/h Transdermal Patch if you are pregnant or breastfeeding. Buvalor 5 mcg/h Transdermal Patch is not recommended for children below 18 years of age. Buvalor 5 mcg/h Transdermal Patch is a habit-forming drug; hence, there is a risk of dependence. Do not stop using this medicine without consulting your doctor, as it may cause withdrawal symptoms like anxiety, increased heart rate, tremors or general unwell feelings. Buvalor 5 mcg/h Transdermal Patch may decrease fertility in men and women. Do not consume alcohol while using Buvalor 5 mcg/h Transdermal Patch as it may increase the risk of side effects.

The Buvalor 5 mcg/h Transdermal Patch contains Buprenorphine. It provides pain relief by acting on specific receptors in the brain and helps in relieving pain. Compared to other opioid analgesics like methadone, Buvalor 5 mcg/h Transdermal Patch has the advantage of having less sedation (sleepiness), decreased respiratory depression, decreased risk of diversion, fewer withdrawal symptoms and lower risk of toxicity at higher doses.

Please do not stop using Buvalor 5 mcg/h Transdermal Patch suddenly, as it may cause withdrawal symptoms. Avoid frequent or high doses as it may lead to addiction. If you are known to be allergic to Buvalor 5 mcg/h Transdermal Patch or any other medicines, please tell your doctor. Do not use Buvalor 5 mcg/h Transdermal Patch if you are pregnant or breastfeeding, as it may cause adverse effects on the baby. Buvalor 5 mcg/h Transdermal Patch is not recommended for children below 18 years of age. Avoid consuming alcohol with Buvalor 5 mcg/h Transdermal Patch as it may increase the risk of side effects. Do not use this medicine if you have used an MAO inhibitor (antidepressants) in the past 14 days, as a dangerous drug interaction could occur. Buvalor 5 mcg/h Transdermal Patch should be taken with extreme caution in patients who have a history of alcoholism or drug abuse. Inform your doctor if you have severe breathing problems, asthma, delirium tremens (confusion and shaking after stopping drinking alcohol), hallucinations (seeing and hearing things that are not there), kidney or liver problems, head injury or brain disease, low blood pressure, urinary disorders (especially linked to enlarged prostate), thyroid problems, adrenocortical disorder (Addison’s disease), depression or other conditions that are treated with antidepressants.